shutterstock_1399766828_jisoo_song
12 December 2023FeaturesAsiaYoung Kim, Yu-Seog WON, In Hwan Kim and Amy (Seung-Hyun) Oh

Why did a South Korea court invoke the ‘extraterritorial activity’ exception in Prevenar 13 case?

In a patent infringement action filed by Pfizer, the Seoul Central District Court rendered a decision finding that another pharmaceutical company directly infringed Pfizer's composition patent—even though the infringer did not make the patented composition in Korea.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
31 August 2021   South Korean officials have urged the US government to help Korean companies gain access to IP related to producing COVID-19 jabs.
Big Pharma
16 March 2021   Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.

More on this story

Big Pharma
16 March 2021   Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.
Big Pharma
31 August 2021   South Korean officials have urged the US government to help Korean companies gain access to IP related to producing COVID-19 jabs.

More on this story

Big Pharma
16 March 2021   Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.
Big Pharma
31 August 2021   South Korean officials have urged the US government to help Korean companies gain access to IP related to producing COVID-19 jabs.